The Applications of Artificial Intelligence in Gastroenterology
A special issue of Cancers (ISSN 2072-6694). This special issue belongs to the section "Cancer Therapy".
Deadline for manuscript submissions: 31 December 2025 | Viewed by 4534
Special Issue Editors
Interests: gastroenterology; endoscopy; gastrointestinal oncology; artificial intelligence
Special Issues, Collections and Topics in MDPI journals
2. Department of Surgery & Cancer, Imperial College London, Hammersmith Hospital, Du Cane Road, London W120HS, UK
Interests: hepatocellular carcinoma; cirrhosis; portal hypertension; gastrointestinal oncology; immunotherapy
Special Issue Information
Dear Colleagues,
The wave of artificial intelligence (AI) is sweeping all fields of medicine, including gastroenterology and gastrointestinal endoscopy.
To date, AI represents a promising solution to overcome human biases, provide diagnostic support, improve clinical decision-making, and standardize outcome assessment in scientific research.
An extensive body of evidence regarding AI in gastroenterology is currently available, but the transition of these technologies to the bedside is still in progress.
This Special Issue aims to summarize and evaluate the applications and recent advances of artificial intelligence in gastroenterology, addressing their effectiveness, limitations, and future perspectives.
Topics covered
- Lesion detection during colonoscopy (ADR, AMR, etc.);
- Quality assessment of colonoscopy (bowel cleansing, mucosal exposure quality, etc.).
- Inflammatory bowel diseases (activity assessment and dysplasia);
- Upper GI (Barrett, early gastric cancer, etc.);
- Capsule endoscopy;
- EUS;
- Hepatology;
- Pancreatology.
Prof. Marcello Maida
Dr. Ciro Celsa
Dr. Louis H. S. Lau
Guest Editors
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Cancers is an international peer-reviewed open access semimonthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2900 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
Keywords
- artificial intelligence
- gastroenterology
- endoscopy
- inflammatory bowel diseases
Benefits of Publishing in a Special Issue
- Ease of navigation: Grouping papers by topic helps scholars navigate broad scope journals more efficiently.
- Greater discoverability: Special Issues support the reach and impact of scientific research. Articles in Special Issues are more discoverable and cited more frequently.
- Expansion of research network: Special Issues facilitate connections among authors, fostering scientific collaborations.
- External promotion: Articles in Special Issues are often promoted through the journal's social media, increasing their visibility.
- e-Book format: Special Issues with more than 10 articles can be published as dedicated e-books, ensuring wide and rapid dissemination.
Further information on MDPI's Special Issue policies can be found here.